These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 4345869

  • 21. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 22. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL, Russell HT.
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [Abstract] [Full Text] [Related]

  • 23. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole.
    Stone M, Dent J, Kardana A, Bagshawe KD.
    Br J Obstet Gynaecol; 1976 Dec; 83(12):913-6. PubMed ID: 188441
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the methods for measuring human chorionic gonadotrophin after hydatidiform mole.
    Salmon JA, Peh KL, Ratnam SS.
    Acta Endocrinol (Copenh); 1976 Mar; 81(3):605-15. PubMed ID: 946350
    [Abstract] [Full Text] [Related]

  • 25. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN, van Trommel NE, Sweep FC, Massuger LF, Thomas CM.
    Int J Biol Markers; 2006 Mar; 21(1):45-9. PubMed ID: 16711513
    [Abstract] [Full Text] [Related]

  • 26. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 27. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM, Thomas CM, Quinn MA, McNally OM, Bekkers RL.
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [Abstract] [Full Text] [Related]

  • 28. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 29. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
    Suzuki A, Kawaguchi K, Konishi I, Ida K, Fujii S, Matsuura S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
    [Abstract] [Full Text] [Related]

  • 30. The use of a radioimmunoassay specific for human chorionic gonadotropin in patients with molar pregnancy and gestational trophoblastic disease.
    Pastorfide GB, Goldstein DP, Kosasa TS.
    Am J Obstet Gynecol; 1974 Dec 15; 120(8):1025-8. PubMed ID: 4372889
    [No Abstract] [Full Text] [Related]

  • 31. Gonadotropin and steroid hormone excretion in trophoblastic neoplasia.
    Ishizuka N, Okamoto M, Tomoda Y.
    Obstet Gynecol; 1973 Jul 15; 42(1):1-11. PubMed ID: 4352641
    [No Abstract] [Full Text] [Related]

  • 32. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr 15; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.
    Kohorn EI.
    Gynecol Oncol; 1993 Feb 15; 48(2):139-47. PubMed ID: 8381374
    [Abstract] [Full Text] [Related]

  • 34. [Clinical aspects of trophoblastic tumors].
    Dapunt O.
    Zentralbl Gynakol; 1970 Oct 24; 92(43):1401-14. PubMed ID: 4321998
    [No Abstract] [Full Text] [Related]

  • 35. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J, Ohba T, Fukunaga M, Katabuchi H.
    Obstet Gynecol; 2011 Oct 24; 118(4):847-53. PubMed ID: 21934448
    [Abstract] [Full Text] [Related]

  • 36. Results of a system of registration and follow-up of patients with hydatidiform mole.
    Katoh T, Endoh N, Kobayashi O, Ishige H, Takamizawa H.
    Asia Oceania J Obstet Gynaecol; 1982 Mar 24; 8(1):47-57. PubMed ID: 6284101
    [No Abstract] [Full Text] [Related]

  • 37. The follow-up of hydatidiform mole with quantitative immunological gonadotrophin assays.
    Teoh ES.
    J Obstet Gynaecol Br Commonw; 1967 Dec 24; 74(6):886-95. PubMed ID: 6071006
    [No Abstract] [Full Text] [Related]

  • 38. [Determination of low unit HCG in chorionic tumor].
    Ishizuka N, Tomoda Y, Aoki T, Mizutani S, Okamoto M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1969 May 24; 21(5):593-4. PubMed ID: 5387739
    [No Abstract] [Full Text] [Related]

  • 39. Post-operative follow-up study of trophoblastic tumors using radioimmunoassay for HCG and LH.
    Chen T.
    Acta Obstet Gynaecol Jpn; 1971 Jan 24; 18(1):13-8. PubMed ID: 4326707
    [No Abstract] [Full Text] [Related]

  • 40. [Trophoblastic tumors].
    Husslein VH, Stöger H.
    Wien Med Wochenschr; 1975 Jan 10; 125(1-3):11-8. PubMed ID: 165642
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.